The western blot and molecular docking results show that minocycline can effectively inhibit the expression of PARP-1 and HDAC3 in LPS-induced A549 cells, which suggests a potential correlation with its protective effect against ALI. The gene discussed is PARP1; the disease is acute respiratory distress syndrome.